Results 221 to 230 of about 3,084 (231)

Juxtaposition of VIP2 (VPAC2) receptor extracellular domains is necessary for VIP but not PACAP activation of the receptor

Biochemical Society Transactions, 1999
E.M. Lutz, C.J. MacKenzie, M.S. Johnson, K. West, A.J. Harmar, R. Mitchell   +5 more
openaire   +1 more source

Targeting pathological B cell receptor signalling in lymphoid malignancies

Nature Reviews Drug Discovery, 2013
Ryan M Young, Louis M Staudt
exaly  

Live Imaging of Altered Period1 Driven GFP Expression in Mice Lacking the VPAC2 Receptor

Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2008
A.T.L. Hughes, C. Guilding, D.G. McMahon, H.D. Piggins   +3 more
openaire   +1 more source

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

Nature Reviews Drug Discovery, 2012
P Mark Hogarth
exaly  

Transient receptor potential channels as therapeutic targets

Nature Reviews Drug Discovery, 2011
Magdalene M Moran, Arpad Szallasi
exaly  

The histamine H3 receptor: from gene cloning to H3 receptor drugs

Nature Reviews Drug Discovery, 2005
Rob Leurs
exaly  

Enabling the 'host jump': structural determinants of receptor-binding specificity in influenza A viruses

Nature Reviews Microbiology, 2014
Yi Shi, Jianxun Qi, George F Gao
exaly  

New Molecular Classifications of Breast Cancer

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

Ca-A Cancer Journal for Clinicians
exaly